Peptan Hydrolyzed Collagen May Prevent Bone Loss

A new study from Rousselot and published in Osteoporosis International in September confirms the benefits of Peptan hydrolyzed collagen on bone health. Research was conducted at AgroParisTech, Nutrition Physiology and Ingestive Behavior laboratory.

The aim of this study was to evaluate the effect of Peptan on the bone health of ovariectomized mice (OVX) of different ages. Animals were divided into different groups: some groups of mice ingested Peptan after OVX; another group of mice ingested Peptan several weeks before OVX and continued over additional weeks; another ingested Raloxifene—a drug commonly indicated for osteoporosis—instead of hydrolyzed collagen.

Twenty-six weeks after the OVX procedure, Peptan hydrolyzed collagen ingestion improved Bone Mineral Density (BMD) and some femur biomechanical parameters. Moreover, hydrolyzed collagen ingestion for one month before surgery prevented a BMD decrease. The third major finding was that Peptan prevented a decrease in BMD as efficiently as Raloxifene. For further information: www.rousselot.com